Affected cats often display vague clinical signs such as weight loss, anorexia, and lethargy or weakness. [2] [3] [4] Even in endemic areas, diagnosis is commonly delayed. 2 Diagnosis most commonly is confirmed by finding H. capsulatum organisms in cytopathologic or histopathologic samples. [2] [3] [4] Treatment includes prolonged administration of antifungal drugs. 2, 3, 5 Despite antifungal treatment, histoplasmosis is commonly fatal with 6-month survival only being 67%. is useful for supporting the diagnosis of disseminated histoplasmosis in cats, with a diagnostic sensitivity (DSe) of 94% when urine is tested. 6 It is also useful for monitoring as an indicator of remission and relapse during and after treatment, respectively. wall and the MV EIA using a polyclonal antibody targeting Histoplasma polysaccharide antigen on the fungal cell wall. [7] [8] [9] The diagnostic performances of the MV and IMMY EIAs have been investigated in humans with suspected histoplasmosis. 7, 9, 10 Initially, the positive agreement of the IMMY EIA with the MV EIA was found to be moderate at 64.5%. 7 However, it improves to 82.3% by making a minor modification to the analytical protocol (use of a wash buffer 0.0 ng/mL calibrator, in addition to the 7 manufacturer-recommended calibrators) and adding an "indeterminate" range of test results to the manufacturer's interpretive criteria. By creating an indeterminate range of test results from 0.11 to 0.49 ng/mL, overall agreement of the IMMY EIA with the MV EIA improves to 90%, but 8% of humans fall within the indeterminate range and required further testing. 9 To our knowledge no published studies describe the use of IMMY EIA in veterinary species. Our aims were (1) to partially validate the IMMY EIA for use in cats and (2) to describe the diagnostic performance of the IMMY EIA in cats and compare its diagnostic performance to that of the current gold standard (MV EIA). 
| MATERIALS AND METHODS

| Cats
| Urine collection and handling
Urine samples were collected by pre-pubic cystocentesis using a 1.5-inch, 22-gauge needle and 5 or 10 mL syringe. Urine was refrigerated for up to 8 hours and then frozen at −80 C for up to 5 years until analyzed. Because of the study design, all urine samples used for MV EIA underwent 2 freeze-thaw cycles. All urine samples used for IMMY EIA underwent 1 freeze-thaw cycle, except those repeated on a different day for determination of inter-assay coefficient of variation (%CV), which underwent 2 freeze-thaw cycles.
| IMMY urine Histoplasma enzyme immunoassay
Testing was performed using commercially available monoclonalantibody agent specific reagents (IMMY) with modification from that previously described. 9 An automated plate washer (Wellwash Versa; 
| Heat fixation
In attempt to improve diagnostic performance, a pre-analytical heat fixation step was added to a subset of samples. All samples for which an adequate volume of urine remained after initial analysis, starting on the 4th day of testing, were reanalyzed after heat fixation. Heat fixation was performed on the same day that samples were analyzed using the IMMY EIA as described above. Urine that was reanalyzed using the heat fixation step was kept at room temperature for <6 hours before analyses. Fixation included heating 200 μL of undiluted urine to 120 C for 3 minutes with a heat block (Isotemp Dry Bath; Thermo Scientific) immediately followed by centrifugation at 10000g for 10 minutes. The sample supernatant was separated immediately and analyzed within 1 hour by IMMY EIA, which was performed as described above.
| MiraVista urine Histoplasma enzyme immunoassay
After the IMMY EIA was performed, samples immediately were refrozen at −80 C and shipped overnight on ice for MV EIA. Urine was kept frozen until being thawed at room temperature for analysis. Antigen tests were performed in 2 batches, as previously described. 8 The 
| Validation-IMMY EIA
Lower limits of quantification, precision or measurement uncertainty, spiked recovery, and diagnostic accuracy (DAc) were used to partially validate the IMMY EIA in cats. The LLOQ was determined by adding 10 SDs to the mean of 40 blank samples. 11 All plates included between 2 and 8 blank samples.
Assay precision or measurement uncertainty was quantified using intra-and inter-assay coefficients of variation (%CV). Intra-assay %CV was calculated using all the samples with results above the LLOQ, with all factors except "well" being held equal. Inter-assay %CV was calculated using samples with results above the LLOQ on initial testing and the same sample repeated on at least 1 additional plate with all factors except "plate," and in some cases "day", being held equal.
Spiked recovery was performed to determine if significant interactions occurred between feline urine and the Histoplasma galactomannan antigen. Urine samples from 5 SPF, purpose-bred research cats were divided into 8 aliquots, and purified antigen solution MV EIA and IMMY EIA using a nonparametric approach as previously described. 15 Statistical significance was set at P ≤ .05.
3 | RESULTS
| Cats
One-hundred and ninety-three urine samples from 105 cats were included in the study. 
| Validation IMMY enzyme immunoassay
Positive and negative controls were within the manufacturer's acceptable concentrations for all plates. The mean (SD) calculated antigen concentration for blank samples was 0.017 ng/mL (0.048) with a calculated LLOQ of 0.50 ng/mL. Intra-assay %CV was 9.9% and interassay %CV was 22.9%. Thirty-five urine samples were analyzed on at least 2 plates and were used to calculate inter-assay %CV. The mean (SD) recovery for urine samples spiked with 0.4, 0. for the IMMY EIA and MV EIA, respectively. These were not significantly different (P = .13; Figure 3 ). −0.14 to 0.09). All discordant results between IMMY EIA and MV EIA occurred on samples for which MV EIA was <1.0 ng/mL.
| Relationship between IMMY enzyme immunoassay and MiraVista enzyme immunoassay before heat fixation
| Heat fixation
Heat fixation was performed on 66 urine samples including those from HP cats during treatment (n = 32) and at the time of diagnosis (11) and those from HN client-owned cats (23). These assays were
performed after the samples were tested without heat fixation. The mean (SD) heat fix IMMY EIA, standard IMMY EIA, and MV EIA were (Table 1) .
| DISCUSSION
Ours is the first study to partially describe and validate the diagnostic performance of the IMMY EIA in cats. Our findings suggest that the IMMY EIA might be useful as a diagnostic test for histoplasmosis in cats. Further modifications of the IMMY EIA are required to achieve the diagnostic performance of the MV EIA.
There are no universally accepted validation methods, and development of an antigen assay is dependent upon the intended use. 16 Based on the World Organization for Animal Health (OIE), "fitness for purpose" categories, the intended purpose for the IMMY EIA are categories 1 and 4 (ie, demonstration of freedom from infection and confirmatory diagnosis of clinical cases, respectively). 16 For these purposes, the OIE considers DSe, DSp, negative and positive predictive values (NPV and PPV), turn-around time, quality assurance capability, and reproducibility and repeatability as essential factors to consider. 16 Many of these factors are described herein.
Considering the intended purpose of the IMMY EIA, our study partially validated the IMMY EIA for the diagnosis of histoplasmosis in cats, because it demonstrated acceptable repeatability, lower limits of quantification, and detection of the analyte of interest across a wide range of known concentrations. Although there is no universally acceptable %CV, based on OIE recommendations, intra-assay %CV should be <15%, except for very low concentrations. 17 The intraassay %CV of 9.9% reported herein suggests adequate repeatability.
Urine is a convenient biological specimen because it is easy to obtain and usually is available in abundance. Potential challenges to using urine include variability in pH and high concentrations of urea and salts. For these reasons, investigating matrix/analyte interactions is important. Universally acceptable spiked sample recovery concentrations are not available, but a suggested range is 80%-120%. 11 All but 2 of the known concentrations had recovery within this range, and the 2 concentrations outside this range were very close to it. This finding suggests that, in the short term, significant interactions do not occur between feline urine and Histoplasma galactomannan antigen that negatively affect the IMMY EIA. Because of a small number of very high antigen concentrations, the upper limit of quantification was not determined. All IMMY EIA results reported herein fall within the previously reported linear range in humans (0.5-50.0 ng/mL). 7 The LLOQ determined in our study was identical to that previously described in humans (0.5 ng/mL). 7 Pending the intended use of the assay, the LLOQ might be higher than the preferred diagnostic cutoff.
If so, the range between the OD diagnostic cutoff and LLOQ would Negative predictive values and PPV are dependent upon the diagnostic performance of the test and the pretest probability of disease. Our study had some limitations. The first is the fact that the clinical diagnosis was used as the standard by which both assays were compared. Clinical diagnoses are not perfect and every organ system in every cat was not sampled. Much effort was used to ensure that HP cats truly had histoplasmosis and that HN cats truly did not. All but 3 HP cats would be considered unequivocal reference standards by the OIE, the highest level. 16 Clinically determining HN cats is considerably more challenging. All HN cats would be considered relative reference standards by the OIE. 16 As such, guidelines to use other well defined test methods were followed. 16 Cytology or histopathology was required when making an alternative diagnosis involving organ systems commonly affected by histoplasmosis. This, in addition to requiring the highly sensitive MV EIA to be negative, was considered adequate for HN cats to serve as negative controls.
A second limitation is the lack of cats with other systemic mycoses to serve as negative controls. In our hospital, other systemic mycoses in cats are very uncommon. Although cross-reactivity of other fungal organisms with the IMMY EIA has not been extensively studied, in 1 study of humans, 6 of 10 blastomycosis controls and 0 of 13 aspergillosis controls tested positive. As such, the DSe of the IMMY EIA reported herein might be lower in locations where other systemic mycoses are more common.
A third limitation was the difference in freeze-thaw cycles between the IMMY EIA and the MV EIA. Additionally, some of the repeat samples used to determine the IMMY EIA inter-assay %CV were subjected to an additional freeze-thaw cycle. In general, freezethaw cycles should be avoided because they can cause degradation of the analyte. Because the MV EIA is only performed in the service laboratory in Indianapolis, Indiana, the samples were refrozen before shipment. Doing so allowed the MV EIA to be performed in batches, and this advantage was considered to outweigh the disadvantages of an additional freeze-thaw cycle.
A fourth limitation was that all samples were stored, some for a prolonged period of time. This did not affect the comparisons between the 2 assays because both were subjected to the essentially the same storage conditions. Studies describing the IMMY EIA in humans also used stored samples; in some instances, samples were stored for several years. 7, 10 We are unaware of published information investigating the effects of storage time on the IMMY EIA, and thus how storage affected the diagnostic performance reported herein is unknown. Future study of the stability of Histoplasma galactomannan in feline urine and the potential effects of storage on the IMMY EIA is warranted.
A final limitation is that heat fixation was not used for all analyses, because it appears to improve specificity. Heat fixation has not been included in published reports of the IMMY EIA in humans and thus was not included in initial testing. Additionally, not all sample volumes
were large enough to be tested using the IMMY EIA with and without heat fixation and with the MV EIA. Further research regarding the effect of heat fixation on the IMMY EIA is needed.
In conclusion, the IMMY EIA might be useful to support the diag- 
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